Research solutions

Sample to Insight COVID-19 wastewater testing

There's growing evidence that successful detection of SARS-CoV-2 RNA in wastewater or natural sewage is a powerful surveillance tool to prevent a surge in COVID-19 infections, and specifically of new variants that are gaining ground in certain communities. QIAGEN supports wastewater-based epidemiology efforts with research tools spanning nucleic acid extraction, amplification and detection, overcoming some of the common challenges with the analytical protocols along the workflow.

Understanding SARS-CoV-2 epidemiology from every angle

Reliable genotyping of virus isolates is essential to understand the evolution, virulence and transmission of SARS-CoV-2 and emerging variants. Moreover, as we move into the respiratory virus season and observe a significant overlap between SARS-CoV-2, flu A/B and RSV A/B symptoms, it is critical to accurately discriminate between the co-circulating viruses by multiplex, real-time PCR. Discover a robust, same-day genotyping approach and a simple, cost-effective multiplexing strategy to match your research goals.

Best in class sample prep

Given the current public health emergency with COVID-19, QIAGEN and other companies are facing unprecedented demand for viral RNA isolation solutions. QIAGEN has developed dedicated solutions for viral RNA isolation that have been optimized for maximum sensitivity and reproducibility.

We recognize that currently, scientists are seeking to use various QIAGEN kits, such as RNeasy, for SARS-CoV-2 RNA isolation from respiratory samples. It is critical to note that these kits have not been designed for isolating viral RNA, and performance of each kit varies. The user must consult the product-specific handbook or user manual. We strongly recommend using only dedicated RNA isolation products for SARS-CoV-2, such as those listed below:

group of scientist, talk, discussion, laboratory, diversity, wearing masks
For QIAcube classic information please visit our resource hub.
Innovative PCR solution for epidemiological research

The QIAprep&amp Viral RNA UM Kit is an innovative, liquid-based approach to viral RNA epidemiology. In one streamlined kit, it combines a two-minute sample preparation with RT-qPCR detection that takes under one hour to generate data. With a simple, three-step workflow, with the possibilities for automation, this kit can significantly accelerate the turnaround time and frequency for epidemiological research.

Pyrosequencing for COVID-19 genotyping

The prevalence of variants must be rapidly detected and reported to keep pace with the mutating SARS-CoV-2 virus. NGS is the current gold standard for genotyping of SARS-CoV-2; however, it is not feasible to genotype samples in real-time on a population-wide scale. RT-qPCR assays could provide an alternative approach that supplements NGS surveillance activities with its ability to genotype all SARS-CoV-2 cases on the day that it is detected. However, it is time-consuming to develop new assays for each emerging mutation, leading to potential delays in surveillance. The Pyrosequencing method presents a cost-effective solution and makes it easier to design new assays for emerging variants.

NGS resources for coronavirus research

Develop a comprehensive picture of circulating variants by ramping up SARS-CoV-2 genomic surveillance with a dramatically faster, high-throughput NGS solution. New QIAseq DIRECT SARS-CoV-2 Kits provide superior sequence uniformity and depth of coverage of the SARS-CoV-2 genome. Maximize efficiency, reduce hands-on time with a 4-hour, automatable workflow and cut down plasticware use by 50%. With QIAseq DIRECT SARS-CoV-2 Kits, you can multiplex up to 768 samples to improve scalability and efficiency. 

2 scientists comparing notes in a lab
Whole genomic sequencing services

QIAGEN Genomic Services provides a comprehensive Sample-to-Insight SARS-CoV-2 Whole Genome Sequencing Services to support your research. Whether you’re studying strain evolution or performing phylogeographic or metagenomic analyses, Genomic Services is the right partner for providing impactful insights and helping accelerate your COVID-19 research. This service uses technology especially designed for SARS-CoV-2 research.

QIAGEN Genomic Service Capabilities
Bioinformatics analysis of SARS-CoV-2 with QIAGEN Digital Insights

To support the efforts of clinical microbiology and public health laboratories involved in SARS-CoV-2 sequencing, QIAGEN offers free temporary licenses to QIAGEN CLC Genomics and QIAGEN Ingenuity Pathway Analysis (IPA) bioinformatics software. In addition, until June 30, 2021 we are offering labs that purchase the QIAseq SARS-CoV-2 Primer Panel Kit (96) a 25% discount off any 1-year subscription to QIAGEN CLC Genomics bioinformatics software.

Additionally, our data scientists have expanded upon recent peer-reviewed research to generate relevant SARS-CoV-2 protein networks. This freely available Coronavirus Network Explorer helps you visualize how SARS-CoV-2 proteins interact with human host proteins to disable protective responses and pathways, and explore hypotheses around ways to fight coronavirus. 

Maximize insights from SARS-CoV-2 T cell immune response

T cells are increasingly recognized for their role in SARS-CoV-2 infection and immunity, and the exploration of immune response markers during COVID-19 infection is becoming the next tool for researching potential improvements in patient management and vaccination guidance in the future.

The QuantiFERON SARS-CoV-2 RUO solution uses a combination of antigens specific to SARS-CoV-2 to stimulate lymphocytes in heparinized whole blood. Plasma from the stimulated samples can be used for detection of cytokines, including IFN-γ.

QFT, QuantiFERON, tubes
Tailored oligonucleotides for SARS-CoV-2 detection

In our effort to support the detection of the SARS-CoV-2 virus, OEM by QIAGEN has ramped up the production of SARS-CoV-2 specific primers and probes. We provide customized oligos defined by our customers, as well as those mentioned in protocols recommended by WHO and the CDC. To meet the high demands, we are currently prioritizing the orders of SARS-CoV-2 specific oligonucleotides. In addition, we have introduced pre-manufacturing of these oligonucleotides to enable quick supply and delivery. To order please send your requests here.

QIAGEN solutions


How can we support your lab?

Reach a specialist about SARS-CoV-2 resources

Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.